Milana Pharm
  • Delivery Platform
  • Analgea SR
  • Products
  • Business Development
  • Contact
Select Page
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation

MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation

by admin | Jun 5, 2019

(GLOBE NEWSWIRE) — MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management and pain, announced today that it received a Notice of Allowance from the United States Patent...
Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

by admin | Mar 13, 2018

(GLOBE NEWSWIRE) — Daré Bioscience, Inc.(NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today announced that it has entered into definitive agreements with Hammock Pharmaceuticals, Inc., TriLogic Pharma LLC and MilanaPharm LLC under which...

Recent Comments

    Archives

    • June 2019
    • March 2018

    Categories

    • News Articles

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2019 Milana Pharm  |  Designed by WebDevil Design  |  Privacy Policy